Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|June 27, 2024
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgeryJason M Samuels, Kevin D Niswender, Christianne L Roumie, et al.Plos One|May 15, 2018
Acute effects of insulin on circulating natriuretic peptide levels in humansKatherine N Bachmann, Serpil Muge Deger, Aseel Alsouqi, et al.Plos One|April 27, 2018
Brief exposure to obesogenic diet disrupts brain dopamine networksRobert L Barry, Nellie E Byun, Jason M Williams, et al.Journal of Medicinal Chemistry|January 20, 2017
Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione CoreKellie D Nance, Emily L Days, C David Weaver, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 18, 2024
Impact of metabolic and weight components on incident asthma using a real-world cohortMelissa H Bloodworth, Patrick J Staso, Shi Huang, et al.Endocrinology, Diabetes & Metabolism|January 31, 2025
The Role of Serum Free Fatty Acids in Endothelium-Dependent Microvascular FunctionAlexander E Sullivan, Meaghan C S Courvan, Aaron W Ada, et al.Molecular Metabolism|June 20, 2014
Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasisHeidi E Kocalis, Scott L Hagan, Leena George, et al.American Journal of Physiology. Endocrinology and Metabolism|January 1, 2009
Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat dietKelly A Posey, Deborah J Clegg, Richard L Printz, et al.Obesity Science & Practice|February 7, 2022
Exploration of an alternative to body mass index to characterize the relationship between height and weight for prediction of metabolic phenotypes and cardiovascular outcomesMegan M Shuey, Shi Huang, Rebecca T Levinson, et al.The Journal of Clinical Investigation|June 25, 2014
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesityZhongyi Chen, Lilu Guo, Yongqin Zhang, et al.Pageof 8